GlassScriptPhysician profile
Andrew J Szabo
NPI 1023338258
$8,724.70
in general payments reported to CMS, 2019-2025
30 companies · $3,896 in 2025
The $3,896 reported for 2025 was more than what 88% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $595 · 2020: $66.38 · 2021: $99.24 · 2022: $2,590 · 2023: $370 · 2024: $1,108 · 2025: $3,896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,819 · Food and Beverage: $1,758 · Long Term Medical Supply Or Device Loan: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,818.96 |
| Food and Beverage | $1,758.36 |
| Long Term Medical Supply Or Device Loan | $796.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,180.68 | 2019-2025 | |
| Stryker Corporation | $2,404.09 | 2025 | Monterey Al |
| Integra Lifesciences Corporation | $851.43 | 2023-2024 | Acell, Integra, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $523.98 | 2019-2025 | Pico, Stravix Pl, Renasys Touch |
| Medtronic, INC. | $443.21 | 2023-2025 | Ligasure, V-Loc 180, Transorb |
| W. L. Gore & Associates, INC. | $345.00 | 2019-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Ethicon US, LLC | $207.53 | 2023-2025 | Echelon Circular, Enseal, Harmonic |
| Novo Nordisk INC | $91.16 | 2020-2023 | Wegovy |
| Access Pro Medical, LLC | $84.32 | 2023 | Matriderm |
| Myriad Genetic Laboratories, INC. | $83.02 | 2021-2025 | Myrisk |
| Braintree Laboratories, INC. | $51.41 | 2021-2023 | Sutab |
| Tela Bio, INC. | $49.40 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Boston Scientific Corporation | $44.07 | 2025 | Spyglass Discover |
| Merck Sharp & Dohme LLC | $43.86 | 2023 | Keytruda, Lynparza |
| Shire North American Group INC | $42.77 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $34.91 | 2024-2025 | 3m Cavilon, Activ.A.C., V.A.C. Veraflo Cleanse Choice |
| Organogenesis INC. | $23.05 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $22.57 | 2025 | |
| Distalmotion US | $21.64 | 2025 | Dexter L6 Robot |
| Tei Biosciences INC | $20.49 | 2019 | |
| Kerecis Limited | $19.46 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Lilly USA, LLC | $18.65 | 2025 | Zepbound, Mounjaro |
| Pacira Pharmaceuticals Incorporated | $18.50 | 2019 | |
| Aroa Biosurgery Incorporated | $17.94 | 2023 | |
| Urgo Medical North America, LLC | $15.00 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Abbott Laboratories | $14.65 | 2019 | |
| Kci USA, INC. | $14.61 | 2019 | |
| Conmed Corporation | $14.00 | 2024 | Airseal |
| Cumberland Pharmaceuticals, INC. | $13.40 | 2019 | |
| Thd America, INC. | $9.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Szabo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.